Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Biomerica (BMRA) Shares Outstanding (2016 - 2026)

Biomerica's Shares Outstanding history spans 16 years, with the latest figure at $3.0 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 18.98% to $3.0 million in Q1 2026 year-over-year; TTM through Feb 2026 was $3.0 million, a 18.98% increase, with the full-year FY2025 number at $2.5 million, up 21.07% from a year prior.
  • Shares Outstanding hit $3.0 million in Q1 2026 for Biomerica, up from $2.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BMRA hit a ceiling of $16.8 million in Q3 2023 and a floor of $2.1 million in Q2 2023.
  • Historically, Shares Outstanding has averaged $8.2 million across 5 years, with a median of $3.0 million in 2026.
  • Biggest five-year swings in Shares Outstanding: tumbled 87.5% in 2024 and later surged 33.87% in 2025.
  • Tracing BMRA's Shares Outstanding over 5 years: stood at $13.5 million in 2022, then grew by 24.8% to $16.8 million in 2023, then crashed by 86.37% to $2.3 million in 2024, then increased by 28.59% to $2.9 million in 2025, then increased by 2.76% to $3.0 million in 2026.
  • Business Quant data shows Shares Outstanding for BMRA at $3.0 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.